Japan-based ENEOS has signed a deal worth $2.17bn (Y336bn) to acquire certain downstream fuel and lubricants businesses in Asia-Pacific (APAC) from Chevron. The assets involved in the deal are in Australia, Indonesia, Malaysia, the Philippines, Singapore and Vietnam <p
The fund underperformed the S&P 500 in Q1 2026 but highlighted Tempus AI as a new position amid healthcare tech growth. Aristotle Capital Management’s Core Equity Fund reported a -4.45% total return in Q1 2026, trailing the S&P 500’s -4.33% decline. The underperformance wa
Barrick Gold’s market cap remains at $75 billion while holding 89 million ounces of gold reserves worth over $400 billion at current prices. Barrick Gold Corp (NYSE: GOLD) holds 89 million ounces of proven and probable gold reserves, valued at over $400 billion at gold pri
Regenxbio (NASDAQ:RGNX) shares gained more than 4% in premarket trading Thursday after investors focused on encouraging clinical trial results for the company’s Duchenne muscular dystrophy therapy, despite weaker-than-expected quarterly financial results. Earnings and Reve
Key Points - Canadian Solar beat first-quarter expectations with revenue of $1.1 billion and gross margin of 25.1%, supported by tariff refund accruals and strong volumes in both solar modules and energy storage. Despite the strong topline, the company still posted a net l
Key Points - Revenue surged in Q1 2026 to $188.9 million, up about 170% year over year, driven mainly by a sharp increase in Bitcoin mining output. Adjusted EBITDA also improved to $14.4 million, though revenue fell sequentially from Q4 due to lower Bitcoin prices and more
Key Points - BioHarvest Sciences reported first-quarter revenue of $8.5 million, up 8% year over year, and kept its 2026 guidance unchanged for both the D2C and CDMO businesses. Cash and deposits rose sharply to $20.2 million from $3.4 million a year earlier. - The company
Key Points - Autolus Therapeutics said first-quarter 2026 product revenue rose to $26.2 million, driven by early traction for AUCATZYL in the U.S. and U.K., and it reaffirmed full-year revenue guidance of $120 million to $135 million. - The company reported a positive gross...</p
Key Points - Anaphylm remains the main focus: Aquestive still plans to resubmit its NDA for the epinephrine sublingual film in Q3 2026, pending FDA feedback on human factors work and other remaining review steps. The company said it has made progress with U.S. and internat
Coles Supermarkets violated consumer law by falsely advertising discounts on 245 products under its Down Down program. An Australian federal court ruled Coles Supermarkets misled shoppers by falsely representing discounts on household products. The case involved 245 items